• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Biomet units lose $2.7M royalty dispute with spine surgeon

Biomet units lose $2.7M royalty dispute with spine surgeon

August 27, 2013 By Brad Perriello

Biomet loses royalties dispute with spine surgeon

Two Biomet subsidiaries are on the hook for some $2.7 million in royalty payments to a prominent spine surgeon it stopped paying in 2008, after a New Jersey appeals court upheld a lower court’s ruling in Dr. Neil Kahanovitz’s favor.

Kahanovitz, the former president of the North American Spine Society, sued Biomet units Electro-Biology Inc. and EBI LLC, winning a breach of contract claim on appeal in 2011. He’d inked a royalties deal worth $250,000 a year in 1992, but stopped actively consulting for them in YY, according to the decision by the New Jersey Superior Court’s Appellate Division.

The contract called for the payments to continue "during the term of this agreement and for so long as Kahanovitz is performing services within the agreement field," according to the appeals court, with the contract set to expire in November 2008.

"The issue is whether the annual $250,000 payment was due even after the November 30, 2008 date referenced in the 2004 Agreement so long as Kahanovitz continued to practice as an orthopedic surgeon," according to court documents.

The court agreed with Kahanovitz that the lower court was correct in considering the testimony of the Electro-Biology and EBI executives who made the deal with the surgeon, according to the documents. Then-EBI CEO James Pastena told the lower court that the agreement was meant to reward Kahanovitz for as long as he practiced in the spine surgery field.

"Pastena testified that the underlying purpose of the agreement encompassed a number of factors: ‘1) To take a leading light, a world renown figure . . . and lock him into the corporation . . . so nobody else could take advantage of his input’ and 2) ‘because of the exclusivity’ of the agreement, to ‘use him as an advisor’ more generally. According to Pastena, ‘this royalty was to continue for as long as he was in the practice of medicine’ and EBI ‘would have stated exactly if [it had] wanted it to end,’" according to the documents. "Pastena also testified that Kahanovitz’s consulting activities as previously defined would end on November 30, 2008, but that the royalty payments would continue so long as Kahanovitz was a practicing spine surgeon. The consulting agreement would be reviewed and modified at the end date if necessary. Pastena explained that as long as Kahanovitz ‘was working as a spine surgeon with his image, with his contacts, with his advice that’s how long this would last.’"

Filed Under: Legal News, News Well, Orthopedics, Spine Tagged With: Biomet, EBI LLC, Electro-Biology Inc., North American Spine Society

More recent news

  • Zynex submits laser pulse oximeter to FDA
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub
  • Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech
  • GE HealthCare launches new MRI scanner
  • HistoSonics earns first major reimbursement win for non-invasive histotripsy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy